PRINT OUT

Leading Products


Aug 11. 2020
(¥ million)

Brand name Active Ingredient Indications Launch Date Sales 2018 Sales 2019 Sales 2020
Apr.-Jun. Apr.-Sep.
(estimated)
Annual
(estimated)
Vidaza azacitidine myelodysplastic syndrome Mar-2011 14,453 15,652 3,761 8,100 16,800
Zalutia tadalafil urinary disorder caused by benign prostatic hyperplasia Apr-2014 12,118 13,328 3,188 5,000 8,400
Uptravi selexipag pulmonary arterial hypertension Nov-2016 4,825 6,182 1,788 3,700 7,900
Tramal, Onetram tramadol hydrochloride cancer pain, chronic pain Sep-2010 7,196 7,153 1,773 3,600 7,400
Adcirca tadalafil pulmonary arterial hypertension Dec-2009 5,173 5,405 1,468 2,800 5,600
Gazyva obinutuzumab CD20-positive follicular lymphoma Aug-2018 1,417 4,527 1,246 2,700 5,600
Cialis tadalafil erectile dysfunction Jul-2009 4,592 4,472 641 1,700 3,200
Azunol Gargle sodium gualenate pharyngitis, tonsillitis, stomatitis, etc. Aug-2002 2,169 2,159 395 950 2,100
Defitelio defibrotide sodium sinusoidal obstruction syndrome Sep-2019 - 1,071 350 1,000 2,200
Erizas dexamethasone cipecilate allergic rhinitis Dec-2009 2,987 2,387 293 750 2,500
Profit in co-promotion 5,057 5,963 2,184 3,950 8,300
Revenues from the licensing of industrial 16,621 15,860 5,105 8,900 19,700
Pharmaceuticals 100,223 101,643 26,209 52,100 110,700
Functional Food 14,492 14,994 3,703 7,400 15,300
Net Sales 114,716 116,637 29,913 59,500 126,000

page-top
不戴乳罩露全乳的熟妇_欧美?亚洲?潮喷?在线_校花的YIN荡大学生活_国产老太婆吃嫩草